These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 16869343)

  • 21. Review article: supra-oesophageal manifestations of gastro-oesophageal reflux disease and the role of night-time gastro-oesophageal reflux.
    Fass R; Achem SR; Harding S; Mittal RK; Quigley E
    Aliment Pharmacol Ther; 2004 Dec; 20 Suppl 9():26-38. PubMed ID: 15527462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extraesophageal manifestations of gastroesophageal reflux disease: cough, asthma, laryngitis, chest pain.
    Saritas Yuksel E; Vaezi MF
    Swiss Med Wkly; 2012; 142():w13544. PubMed ID: 22442097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Respiratory involvement in the gastroesophageal reflux disesease.
    Mureşan I; Picos A; Grad S; Dumitrascu DL
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):662-71. PubMed ID: 22046769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extraesophageal manifestations in gastroesophageal reflux disease.
    Jaspersen D
    Minerva Gastroenterol Dietol; 2006 Sep; 52(3):269-74. PubMed ID: 16971871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review article: the role of acid suppression in patients with non-erosive reflux disease or functional heartburn.
    DeVault KR
    Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():33-9. PubMed ID: 16483268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extra-oesophageal presentation of gastro-oesophageal reflux disease.
    Rathod NR
    J Indian Med Assoc; 2010 Jan; 108(1):18-20, 22. PubMed ID: 20839575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural history of gastro-oesophageal reflux disease without oesophagitis (NERD)--a reappraisal 10 years on.
    Pace F; Bollani S; Molteni P; Bianchi Porro G
    Dig Liver Dis; 2004 Feb; 36(2):111-5. PubMed ID: 15002817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
    de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
    Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Supra-oesophageal manifestations of gastro-oesophageal reflux disease.
    Rodríguez-Téllez M
    Drugs; 2005; 65 Suppl 1():67-73. PubMed ID: 16335860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extraesophageal manifestations of gastroesophageal reflux disease.
    Vaezi MF
    Clin Cornerstone; 2003; 5(4):32-8; discussion 39-40. PubMed ID: 15101493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastroesophageal reflux disease (GERD) in children.
    Poddar U
    Paediatr Int Child Health; 2019 Feb; 39(1):7-12. PubMed ID: 30080479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extra-esophageal disorders in gastroesophageal reflux disease.
    Jaspersen D
    Dig Dis; 2004; 22(2):115-9. PubMed ID: 15383751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease.
    Savarino E; Gemignani L; Pohl D; Zentilin P; Dulbecco P; Assandri L; Marabotto E; Bonfanti D; Inferrera S; Fazio V; Malesci A; Tutuian R; Savarino V
    Aliment Pharmacol Ther; 2011 Aug; 34(4):476-86. PubMed ID: 21671968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Updates in the field of non-esophageal gastroesophageal reflux disorder.
    Ghisa M; Della Coletta M; Barbuscio I; Marabotto E; Barberio B; Frazzoni M; De Bortoli N; Zentilin P; Tolone S; Ottonello A; Lorenzon G; Savarino V; Savarino E
    Expert Rev Gastroenterol Hepatol; 2019 Sep; 13(9):827-838. PubMed ID: 31322443
    [No Abstract]   [Full Text] [Related]  

  • 35. The influence of co-morbid IBS and psychological distress on outcomes and quality of life following PPI therapy in patients with gastro-oesophageal reflux disease.
    Nojkov B; Rubenstein JH; Adlis SA; Shaw MJ; Saad R; Rai J; Weinman B; Chey WD
    Aliment Pharmacol Ther; 2008 Mar; 27(6):473-82. PubMed ID: 18194508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cough threshold in reflux oesophagitis: influence of acid and of laryngeal and oesophageal damage.
    Benini L; Ferrari M; Sembenini C; Olivieri M; Micciolo R; Zuccali V; Bulighin GM; Fiorino F; Ederle A; Cascio VL; Vantini I
    Gut; 2000 Jun; 46(6):762-7. PubMed ID: 10807885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Respiratory manifestations of gastro-oesophageal reflux in children.
    de Benedictis FM; Bush A
    Arch Dis Child; 2018 Mar; 103(3):292-296. PubMed ID: 28882881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term outcome of Nissen fundoplication in non-erosive and erosive gastro-oesophageal reflux disease.
    Broeders JA; Draaisma WA; Bredenoord AJ; Smout AJ; Broeders IA; Gooszen HG
    Br J Surg; 2010 Jun; 97(6):845-52. PubMed ID: 20473997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extraesophageal manifestations of gastroesophageal reflux disease.
    Hom C; Vaezi MF
    Gastroenterol Clin North Am; 2013 Mar; 42(1):71-91. PubMed ID: 23452632
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.